C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia
暂无分享,去创建一个
[1] A. Falus,et al. Hormonal regulation of complement biosynthesis in human cell lines--I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. , 1990, Molecular immunology.
[2] G. Remuzzi,et al. Effect of low‐dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy‐induced hypertension , 1990, The New England journal of medicine.
[3] E. Frigas. Angioedema with acquired deficiency of the C1 inhibitor: a constellation of syndromes. , 1989, Mayo Clinic proceedings.
[4] E. Ruppin,et al. The use of aspirin to prevent pregnancy‐induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies , 1989, The New England journal of medicine.
[5] C. Greenberg,et al. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. , 1989, Obstetrics and gynecology.
[6] C. Hack,et al. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis. , 1988, Blood.
[7] F. Vivanco,et al. Acquired C1-inhibitor deficiency associated with a lupus-like anticoagulant activity. , 1988, Annals of allergy.
[8] C. Feighery,et al. Autoantibody-mediated acquired deficiency of C1 inhibitor. , 1988, The New England journal of medicine.
[9] R. Thorpe,et al. Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP) II. EVALUATION IN A VARIETY OF CLINICAL CONDITIONS , 1988, British journal of haematology.
[10] J. Widmann,et al. Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia. , 1987, The American journal of medicine.
[11] J. Gilabert,et al. Fibrinolysis in pre-eclampsia , 1987 .
[12] H. Schwarz,et al. PROTEIN C AND PROTEIN S IN MILD AND MODERATE PREECLAMPSIA , 1987, Thrombosis and Haemostasis.
[13] A. Schmaier,et al. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor. , 1987, Archives of biochemistry and biophysics.
[14] J. Alsenz,et al. Autoantibody-mediated acquired deficiency of C1 inhibitor. , 1987, The New England journal of medicine.
[15] B. Lämmle,et al. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. , 1987, Seminars in thrombosis and hemostasis.
[16] T. Terao,et al. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. , 1987, Gynecologic and obstetric investigation.
[17] F. Hentges,et al. Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations. , 1986, The Journal of allergy and clinical immunology.
[18] C. Feighery,et al. An IgG autoantibody which inactivates C1¯-inhibitor , 1986, Nature.
[19] J. Grudzinskas,et al. Complement activation, circulating protease inhibitors and pregnancy‐associated proteins in severe preeclampsia , 1986, British journal of obstetrics and gynaecology.
[20] D. Chou. Textbook of Clinical Chemistry , 1986 .
[21] J. Gilabert,et al. Fibrinolytic Activity and Protein C in Preeclampsia , 1986, Thrombosis and Haemostasis.
[22] J. Westergaard,et al. Quantitative Comparison of Circulating Immune Complexes in Normal Pregnancy and Pregnancy Related Hypertension , 1986, Acta obstetricia et gynecologica Scandinavica.
[23] J. Jespersen,et al. Increased Euglobulin Fibrinolytic Potential in Women on Oral Contraceptives Low in Oestrogen – Levels of Extrinsic and Intrinsic Plasminogen Activators, Prekallikrein, Factor XII, and C1-Inactivator , 1985, Thrombosis and Haemostasis.
[24] G. Camussi,et al. Immune complexes in preeclampsia and normal pregnancy. , 1985, American journal of obstetrics and gynecology.
[25] F. Rosen,et al. Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies. , 1985, The Journal of clinical investigation.
[26] T. Meade,et al. Haemostasis in Normal Pregnancy , 1984, Thrombosis and Haemostasis.
[27] J. T. ten Cate,et al. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. , 1984, American journal of obstetrics and gynecology.
[28] J. Weitz,et al. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. , 1984, Blood.
[29] J. Hustin,et al. Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. , 1985, Placenta.
[30] D. Ogston,et al. Blood levels of proteinase inhibitors in pre‐eclampsia , 1983, British journal of obstetrics and gynaecology.
[31] H. Schuurman,et al. IMMUNE COMPLEXES IN SKIN OF PATIENTS WITH PRE-ECLAMPTIC TOXAEMIA , 1982, The Lancet.
[32] J. Stuart,et al. Haemostatic and rheological changes in normal pregnancy and pre‐eclampsia , 1982, British journal of haematology.
[33] M. Schalekamp,et al. Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin. , 1982, The Journal of clinical endocrinology and metabolism.
[34] J. Balasch,et al. Further Evidence Against Preeclampsia as an Immune Complex Disease , 1981, Obstetrics and gynecology.
[35] M. Blombäck,et al. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. , 1981, Gynecologic and obstetric investigation.
[36] O. Ratnoff,et al. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. , 1980, The Journal of laboratory and clinical medicine.
[37] G. Boss,et al. Acquired C1 Esterase Inhibitor Deficiency and Angioedema: A Review , 1979, Medicine.
[38] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[39] R. Levinsky,et al. IMMUNE COMPLEXES IN PREGNANCY , 1978, The Lancet.
[40] J. Fink,et al. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol. , 1978, The Journal of allergy and clinical immunology.
[41] J. Volanakis,et al. A search for antigen-antibody complexes in pre-eclampsia: further evidence against immunologic pathogenesis. , 1978, American journal of obstetrics and gynecology.
[42] P. Harber,et al. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. , 1978, Annals of internal medicine.
[43] R. Colman,et al. Plasma kallikrein activation and inhibition during typhoid fever. , 1978, The Journal of clinical investigation.
[44] R. Colman,et al. Effect of Clofibrate on Intravascular Coagulation in Hyperlipoproteinemia , 1977, Circulation.
[45] D. Ogston,et al. SEQUENTIAL STUDIES ON COMPONENTS OF THE HAEMOSTATIC MECHANISM IN PREGNANCY WITH PARTICULAR REFERENCE TO THE DEVELOPMENT OF PRE‐ECLAMPSIA , 1976, British journal of obstetrics and gynaecology.
[46] R. Colman,et al. Kinin activation in the blood of patients with sepsis. , 1976, Surgery, gynecology & obstetrics.
[47] F. Arias,et al. Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. , 1976, The New England journal of medicine.
[48] R. Kallen,et al. A Study of the Plasma Kinin-generating System in Children with the Minimal Lesion, Idiopathic Nephrotic Syndrome , 1975, Pediatric Research.
[49] W. D. Creighton,et al. Immunological studies of the human placenta. Characterization of immunoglobulins on trophoblastic basement membranes. , 1974, The Journal of clinical investigation.
[50] R. Colman,et al. Kallikrein-kinin system in postgastrectomy dumping syndrome. , 1974, Annals of internal medicine.
[51] R. Colman,et al. Activation of Hageman factor in the nephrotic syndrome. , 1974, The American journal of medicine.
[52] J. Lawrence,et al. Immunofluorescent Studies in Renal Biopsies in Pre-eclampsia , 1974, British medical journal.
[53] K.,et al. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. , 1973, The Journal of clinical investigation.
[54] Mason Jw,et al. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia, or liver disease. , 1971 .
[55] C. Forbes,et al. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. , 1970, The Journal of laboratory and clinical medicine.
[56] R. Colman,et al. Plasma kallikrein and Hageman factor in Gram-negative bacteremia. , 1970, Annals of internal medicine.
[57] G. P. Lewis. Kinins in Inflammation and Tissue Injury , 1970 .
[58] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.